Director, Patient Advocacy – Immunology & Autoimmune Cell Therapy
Bristol-Myers Squibb
- Location
- Remote - United States - US
- Work model
- Remote
- Level
- Staff
- H-1B history
- 57 approvals (FY2023)
- Posted
- Aug 17, 2026
About this role
Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us . Reporting to the Sr. Director, Patient Advocacy, Immunology, Cardiovascular & Autoimmune Cell Therapy, the Director, Patient Advocacy, Immunology & Autoimmune Cell Therapy will serve as a strategic and operational leader within the Global Patient Advocacy organization, with cross-therapeutic area accountability spanning immunology (lupus, Sjogren’s disease, psoriatic arthritis) and autoimmune cell therapy (rheumatology). This role will play a pivotal part in embedding the patient voice throughout the full cell therapy lifecycle — from drug development through commercialization — ensuring that patient community insights meaningfully shape BMS strategy, clinical programs, and product launches. The Director will lead the design and execution of patient advocacy strategies across disease areas in both immunology and autoimmune cell therapy programs owning both the operational infrastructure and the strategic relationships that make those programs successful. Additionally, the individual will lead launch readiness efforts for immunology products in lupus and Sjogren’s disease as well as autoimmune cell therapy programs in rheumatology, partnering closely with commercial, medical, policy, market access, and communications functions to position BMS as the trusted and preferred partner to the patient advocacy community. The ideal candidate is a seasoned advocacy professional who thinks strategically, executes tactically, builds trusted relationships at all levels, and thrives in a complex, fast-paced, matrixed environment.
Key Responsibilities
Strategic Leadership & Launch Excellence Lead workstreams across immunology and autoimmune cell therapy programs to collect and synthesize patient insights and translate them into actionable, program and portfolio-level strategic plans. Lead patient advocacy strategy, execution and launch readiness for immunology and autoimmune cell therapy programs, ensuring the patient voice is integrated from pre-launch through post-launch phases. Define and execute advocacy strategies in collaboration with cross functional therapeutic area teams to support successful product launches. Drive the development of high-impact, insight-driven advocacy plans that reflect deep knowledge of the patient community landscapes and that shape the environment to enable greater patient access. Champion the integration of patient and caregiver perspectives into BMS immunology and autoimmune cell therapy programs, from mid-late clinical development through commercialization, ensuring strategies are patient-centered and aligned with the company strategy. Generate innovative business concepts and continuously search for novel applications of advocacy strategies to support evolving pipeline and launch priorities. External Stakeholder Engagement & Relationship Management Cultivate and manage high-priority relationships with patient advocacy organizations and patient communities within relevant therapeutic areas in immunology and cell therapy, including national, regional and global organizations. Manage grants,